|
LRRC40 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68998148808441E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.9649173661237E-12 |
| Normal-vs-Stage2 |
6.98989977010456E-10 |
| Normal-vs-Stage3 |
1.68290004154414E-09 |
| Normal-vs-Stage4 |
1.08310027613356E-10 |
| Stage1-vs-Stage2 |
1.532370E-01 |
| Stage1-vs-Stage3 |
4.469400E-01 |
| Stage1-vs-Stage4 |
6.948000E-02 |
| Stage2-vs-Stage3 |
4.871200E-01 |
| Stage2-vs-Stage4 |
7.711400E-01 |
| Stage3-vs-Stage4 |
3.164600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.23088214568179E-12 |
| Normal-vs-AfricanAmerican |
2.845500E-04 |
| Normal-vs-Asian |
4.04479999494001E-08 |
| Caucasian-vs-AfricanAmerican |
5.580600E-01 |
| Caucasian-vs-Asian |
7.304000E-01 |
| AfricanAmerican-vs-Asian |
4.709400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.13662462459297E-12 |
| Normal-vs-Female |
2.60924615247404E-12 |
| Male-vs-Female |
4.702200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.36510003301282E-09 |
| Normal-vs-Age(41-60Yrs) |
1.90736315630602E-13 |
| Normal-vs-Age(61-80Yrs) |
4.21339629852469E-11 |
| Normal-vs-Age(81-100Yrs) |
5.014400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.314100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.932200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.684800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.897600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.732010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.855760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.749000E-01 |
| Classical-VS-Follicular |
6.950200E-04 |
| Classical-VS-Other |
3.102600E-01 |
| Classical-VS-Normal |
1.5024004262898E-10 |
| Tall-VS-Follicular |
7.112500E-02 |
| Tall-VS-Other |
4.128000E-01 |
| Tall-VS-Normal |
6.33580000000133E-05 |
| Follicular-VS-Other |
9.069200E-01 |
| Follicular-VS-Normal |
2.43793873977438E-12 |
| Other-VS-Normal |
1.844110E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.06421554796543E-14 |
| Normal-vs-N1 |
2.87400003795568E-09 |
| N0-vs-N1 |
7.272600E-01 |
|
|
